However, subsequent events, perhaps chronic exposure to inflammatory cells/cytokines, may lead to down-regulation of CEACAM1, thus accounting for the over-all decrease in CEACAM1 observed in breast cancer. The gene discussed is CEACAM1; the disease is breast carcinoma.